Drugmaker Eli Lilly walks back 2024 forecast after 3Q earnings miss

Finance Business News

Drugmaker Eli Lilly walks back 2024 forecast after 3Q earnings miss
IN State WireRetail And WholesaleBusiness
  • 📰 AP
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Eli Lilly is dialing back its 2024 forecast after underwhelming Wall Street with third-quarter earnings and sales from two key drugs that missed expectations. The drugmaker on Wednesday chopped a few dollars off its earnings guidance for the year after raising that forecast well beyond analyst expectations in previous quarters.

Two closing arguments show the stark choice between Trump and HarrisHow Trump's rhetoric has grown more disjointed and erraticFreddie Freeman homers again for Dodgers early in Game 4 to set a pair of World Series recordsIn 'Ibelin' and 'Grand Theft Hamlet,' video game realms draw filmmakers with virtual camerasHow to watch comet Tsuchinshan-Atlas this OctoberFACT FOCUS: Trump repeated election lies in his interview with Joe Rogan.

The company brought in $3.1 billion in sales from Mounjaro and another $1.3 billion from Zepbound, which debuted in the U.S. market nearly a year ago. TD Cowen analyst Steve Scala said in a note that both drugs missed expectations, and he wanted to learn more about whether the drop was a “temporary flattening or new trend.”

Lilly also booked higher research and development and marketing, selling and administrative expenses in the quarter.Analysts expected earnings of $1.45 per share on $12.09 billion in revenue, according to FactSet. For the full year, Lilly now forecasts adjusted earnings to range between $13.02 and $13.52 per share. The company had predicted more than $16 per share in August, which was more than $2 higher than consensus at the time.Murphy covers how people and businesses navigate the U.S. health care system. He is a member of AP’s Health and Science team.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

AP /  🏆 728. in US

IN State Wire Retail And Wholesale Business Diabetes Financial Markets

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Fall 2024 Winter 2025 2024 / 2025 » Fashion AllureFall 2024 Winter 2025 2024 / 2025 » Fashion AllureLatest Fashion Trends, Shoes and Accessories, Celebrity Style
Read more »

Top Fall 2024 / Winter 2025 Shoe Trends 2024 / 2025 » Fashion AllureTop Fall 2024 / Winter 2025 Shoe Trends 2024 / 2025 » Fashion AllureLatest Fashion Trends, Shoes and Accessories, Celebrity Style
Read more »

Top Fall 2024 / Winter 2025 Bag Trends 2024 / 2025 » Fashion AllureTop Fall 2024 / Winter 2025 Bag Trends 2024 / 2025 » Fashion AllureLatest Fashion Trends, Shoes and Accessories, Celebrity Style
Read more »

2024 United States Grand Prix 2024 Odds, Picks & Predictions: Norris Keeps Gaining on Verstappen2024 United States Grand Prix 2024 Odds, Picks & Predictions: Norris Keeps Gaining on VerstappenLando Norris and Oscar Piastri are slotted ahead of 3-time United States Grand Prix winner Max Verstappen in the opening odds for this year's race.
Read more »

Spurs Starter, October 21, 2024: Spurs Introduce 2024-25 Season RosterYour daily briefing on what's going on with the San Antonio Spurs, including news, draft and more.
Read more »

Amazon Kindle Paperwhite Signature Edition (2024) vs. Kindle Paperwhite (2024): Which wins out?Amazon Kindle Paperwhite Signature Edition (2024) vs. Kindle Paperwhite (2024): Which wins out?Amazon has just launched new Kindles, but should you pay $40 more for the Amazon Kindle Paperwhite Signature Edition (2024) over the Kindle Paperwhite (2024)?
Read more »



Render Time: 2025-02-15 07:42:06